advertisement

Partnering Deals and Alliances with Big Pharma:Industry Trends, Size and Shares Research Report

33 %
67 %
advertisement
Information about Partnering Deals and Alliances with Big Pharma:Industry Trends, Size and...
Business & Mgmt

Published on March 5, 2014

Author: Mathyupol

Source: slideshare.net

Description

Partnering Deals and Alliances with Big Pharma:Industry Trends, Size and Shares Research Report
@ http://www.researchmoz.us/partnering-deals-and-alliances-with-big-pharma-report.html
advertisement

Partnering Deals and Alliances with Big Pharma The Partnering Deals and Alliances with Big Pharma report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big pharma companies. Partnering Deals and Alliances with Big Pharma provides the user with the following key benefits: Detailed partnering activity profiles for each of the top 50 big pharma companies Over 300 charts showing a company’s dealmaking activity since 2007, allowing quick identification potential partners Partnering therapy focus revealed Partnering activity since 2009 – number of deals per year Full listing of partnering deals Activity by deal type Activity by industry sector Activity by phase of development Activity by technology type Activity by therapeutic area Comprehensive access to over 3,000 partnering deals as recorded at Current Agreement, together with contract documents if available Insight into the terms included in a partnering agreement, together with real world clause examples, via contract documents Understand the key deal terms the company has agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies The Partnering Deals and Alliances with Big Pharma report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big pharma companies. This premier report provides all the information you require to better understand big pharma partnering. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. Over 300 charts allow quick understanding of each big pharma companies dealmaking trends over the last four years. This report contains over 3,000 links to online copies of actual partnering deals as recorded at Current Agreement, together with contract documents if submitted to the Securities Exchange Commission by bigpharma and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. The initial chapters of this report provide an orientation of big pharma’s dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst Chapter 2 lists the top 50 leading big pharma companies based on 2012 pharmaceutical revenues and dealmaking activity since 2009. Chapter 3 reviews the top partnering and M&A deals of 2009-2014 according to reported deal size. Chapter 4 provides a summary on best practice on how to submit an opportunity to big pharma, to ensure building of relationships and to obtain a prompt assessment and response from the business development function of the prospective partner. Chapter 5 lists forthcoming partnering events where valuable face to face meetings with big pharma provide a highly effective means of obtaining interest in novel opportunities. These events are where dealmaking gets initiated through numerous back to back meetings. The main body of the report is provided in chapter 6. In-depth profiles of every big pharma company provide everything required to assess the suitability of a company as a prospective partner. Each profile includes a company overview, partnering activity according to deal type, phase of development, therapy area and technology type. Each company profile provides a comprehensive listing of deal records available at Current Agreements, each of which links direct to an online copy of the actual deal record plus contract document if filed with the SEC. One of the key aspects of partnering is conducting due diligence on a partner to determine under what terms a prospective partner agrees to a partnering relationship. Understanding the flexibility of a prospective partners’ negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not. This data driven report contains over 3,000 links to online copies of actual deal records at Current Agreements and contract documents, where submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. In addition, contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. In summary, the report provides the reader with the tools necessary to make successful contact with the right big pharma partners effectively and efficiently. Key benefits Partnering Deals and Alliances with Big Pharma provides the user with the following key benefits: Detailed partnering activity profiles for each of the top 50 big pharma companies Over 300 charts showing a company’s dealmaking activity since 2009, allowing quick identification potential partners Partnering therapy focus revealed Partnering activity since 2009 – number of deals per year Full listing of partnering deals Activity by deal type Activity by industry sector Activity by phase of development Activity by technology type Activity by therapeutic area Comprehensive access to over 3,000 partnering deals as recorded at Current Agreement, together with contract documents if available Insight into the terms included in a partnering agreement, together with real world clause examples, via contract documents Understand the key deal terms the company has agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies Report scope Partnering Deals and Alliances with Big Pharma is intended to provide the reader with an in-depth understanding of the partnering activities of the leading fifty big pharma companies worldwide, enabling the effective assessment and selection of partners of choice, based on the latest knowledge of a company’s partnering. Partnering Deals and Alliances with Big Pharma includes: Detailed company profiles for each of the top 50 big pharma companies, including: Partnering interests and indications Partnering activity since 2009 Partner companies since 2009 Partnering activity since 2009 by: Partner company Deal type Industry sector Stage of development Technology type Therapy area Over 300 charts showing the dealmaking activity of each company since 2009 The tools to enable effective and efficient preparation for partnering negotiation with big pharma 3,000 partnering deals as recorded at Current Agreement, together with contract documents if available The leading M&A and partnering deals by value 2009-2014 The Partnering Deals and Alliances with Big Pharma report also provides comprehensive access to available contract documents for each of the fifty big pharma companies. Analyzing actual company agreements allows assessment of the following: What is actually granted by the agreement to the partner company? What exclusivity is granted? What is the payment structure for the deal? How are sales and payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs handled and owned? Who is responsible for commercialization? Who is responsible for development, supply, and manufacture? How is confidentiality and publication managed? How are disputes to be resolved? Under what conditions can the deal be terminated? What happens when there is a change of ownership? What sublicensing and subscontracting provisions have been agreed? Which boilerplate clauses does the company insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for agreement law? Partnering Deals and Alliances with Big Pharma provides the user with the following key benefits: Detailed partnering activity profiles for each of the top 50 big pharma companies Over 300 charts showing a company’s dealmaking activity since 2009, allowing quick identification potential partners Partnering therapy focus revealed Partnering activity since 2009 – number of deals per year Full listing of partnering deals Activity by deal type Activity by industry sector Activity by phase of development Activity by technology type Activity by therapeutic area Comprehensive access to over 3,000 partnering deals as recorded at Current Agreement, together with contract documents if available Insight into the terms included in a partnering agreement, together with real world clause examples, via contract documents Understand the key deal terms the company has agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies Partnering Deals and Alliances with Big Pharma

table Of Content executive Summary chapter 1 – Introduction chapter 2 – Big Pharma Top 50 Dealmaking Activity 2.1. Introduction 2.2. Big Pharma Partnering Over The Years 2.4. Big Pharma Partnering By Deal Type 2.5. Big Pharma Partnering Industry Sector 2.6. Big Pharma Partnering By Stage Of Development 2.7. Big Pharma Partnering By Technology Type 2.8. Big Pharma Partnering By Therapy Area 2.9. Big Pharma M&a Over The Years chapter 3 – Top Big Pharma Deals By Value 3.1. Introduction 3.2. Big Pharma Partnering 3.3. Big Pharma M&a chapter 4 – Submitting Opportunities To Big Pharma 4.1. How To Submit An Opportunity 4.2. Opportunity Submission Template 4.3. Sending Emails 4.4. Face To Face At Partnering Events 4.5. Online Submission Forms chapter 5 – Forthcoming Big Pharma Partnering Events 5.1. Forthcoming Events chapter 6 – Big Pharma Company Profiles 6.1. Introduction 6.2. Field Definitions 6.3. Company Profiles abbott actavis Inc.( Formerly Watson) allergan amgen astellas astrazeneca baxter International bayer biogen Idec boehringer Ingelheim bristol-myers Squibb celgene csl daiichi Sankyo dainippon Sumitomo eisai eli Lilly endo Pharmaceuticals forest Laboratories fresenius galderma gilead Sciences glaxosmithkline grifols hospira johnson & Johnson Partnering Deals and Alliances with Big Pharma

kyowa Hakko Kirin lundbeck menarini merck & Co merck Kgaa mitsubishi Tanabe mylan novartis novo Nordisk otsuka pfizer purdue ranbaxy Laboratories roche sanofi servier shionogi shire stada takeda teva ucb valeant warner Chilcott chapter 7 – Resources appendices appendix 1 – Deal Type Definitions appendix 2 – Example Contract Document about Wildwood Ventures current Partnering current Agreements recent Titles From Currentpartnering order Form – Reports ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Partnering Deals and Alliances with Big Pharma

Add a comment

Related presentations

Canvas Prints at Affordable Prices make you smile.Visit http://www.shopcanvasprint...

30 Días en Bici en Gijón organiza un recorrido por los comercios históricos de la ...

Con el fin de conocer mejor el rol que juega internet en el proceso de compra en E...

With three established projects across the country and seven more in the pipeline,...

Retailing is not a rocket science, neither it's walk-in-the-park. In this presenta...

What is research??

What is research??

April 2, 2014

Explanatory definitions of research in depth...

Related pages

In-depth understanding of the partnering activities of Big ...

ResearchMoz.us include new market research report "Partnering Deals and Alliances with Big Pharma : Industry Size, Shares, Growth, Analysis, Trends And ...
Read more

Top 50 Big Pharma Partnering and M&A Deal Trends -- NEW ...

... Top 50 Big Pharma Partnering and M&A Deal Trends. ... The Partnering Deals and Alliances with Big Pharma report provides ... to reported deal size.
Read more

Top 50 Big Pharma Partnering and M&A Deal Trends 2010-2015 ...

Top 50 Big Pharma Partnering and M&A Deal Trends ... Deals and Alliances with Big Pharma report ... market research reports ...
Read more

Worldwide Marine Biotech Market 2016 | Global Scenario ...

ResearchMoz.us include new market research report " Global ... Trends, Industry Analysis, Size, Share And ... Partnering Deals and Alliances with Big Biotech.
Read more

Big pharma merger and acquisition activity | Current ...

Company partnering reports; 2014 Deals and Alliances ... at recent big pharma partnering and M&A ... with relative company size based on ...
Read more

partnering360

Gain the insight you need to do better deals. Tune in to partnering360: ... The partnering360 blog provides timely ... leading industry partnering ...
Read more

Global Viral Partnering Terms and Agreements 2010-2015 ...

Trends in viral partnering deals ... each report of all viral partnering deals ... all market research reports from ...
Read more